Défense de thèse de Mathilde COLINET
Sciences biomédicales et pharmaceutiques
Infos
Le lundi 12 janvier 2026 décembre, Madame Mathilde COLINET, titulaire d'un Master en biologie des organismes et écologie, finalité approfondie (UCL) et d’un Certificat de formation à la recherche en sciences biomédicales et pharmaceutiques, présentera l'examen en vue de l'obtention du grade de Doctorat en sciences biomédicales et pharmaceutiques, sous la direction de Madame Ira ESPUNY CAMACHO et de Monsieur Laurent NGUYEN.
Cette épreuve consistera en la défense publique d'une thèse intitulée : "3D human cortical brain organoids derived from hPSC to model health and disease in the human brain".
Le jury sera composé de :
Brigitte MALGRANGE (Présidente), Pierre CLOSE (Secrétaire), Tristan BOUSCHET, Silvia CAPELLO, Lucia CHAVEZ-GUTTIERREZ, Ira ESPUNY CAMACHO, Pierre MAQUET, Laurent NGUYEN, Anne-Simone PARENT.
Résumé de la thèse
This thesis investigates human brain development and diseases related to adulthood using brain organoids to overcome the limitation to the access of human brain tissue. First, we studied the healthy development of the human brain. We demonstrated a time-dependent emergence of neuronal and glia populations in our model alongside with an increase in calcium activity and changes in axonal transport related to maturation. Then, we investigated the impact of SARS-CoV2 infection on brain organoids and identified astrocytes as the major cell type infected. This infection triggers a global mild inflammation and upregulates the expression of astrogliosis markers. However, no cell death was detected, rather an upregulation of markers promoting cell survival was observed. Finally, we focused on the study of the development of Alzheimer’s disease using cell lines derived from patients. The characterization of our model revealed an early stage of the disease associated with neuronal hyperexcitability. We also showed lower levels of cathepsin D in lysosomes independent from amyloid beta peptide levels. Overall, this thesis showed that brain organoids are powerful models to understand the development and functionality of our human brain but also to decipher the mechanisms of viral infection and neurodegenerative diseases such Alzheimer’s disease.
